Abstract
Mast cells derive from bone marrow stem cells, are ubiquitously distributed resident tissue cells, and are particularly frequent in the lamina propria of epithelial organs, including the skin. The cells are characterized and distinguishable from other cells by their electrondense cytoplasmatic granules, their contents of mediators like histamine, heparin and tryptase, and by their surface receptors for SCF (c-kit) and IgE (the high affinity IgE receptor, FcɛRI). Basophils which belong to the granulocytic series of the bone marrow and reside primarily in peripheral blood, are often grouped with mast cells since they share many properties with these cells except for their morphology and their lack of tryptase and c-kit. Mast cells also have a number of properties in common with other tissue resident and infiltrating inflammatory cells like the receptors c-kit on melanocytes, FceRI on Langerhans cells, and C3bR, C5aR and FcγRIII on monocytes and granulocytes. Furthermore, like most inflammatory cells, they are able to produce a broad range of mediators including leukotrienes, platelet activating factor (PAF) and cytokines. While mast cells have traditionally been viewed as primary effector cells of immediate type allergic reactions, their potential role in diverse other immunological and inflammatory processes has become more and more apparent in recent years (for review, see [1]).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Weber S, Krüger-Krasagakes S, Grabbe J, Zuberbier T, Czarnetzki BM (1995) Mast cells. Int J Dermatol 34: 1–10
Haas N, Toppe E, Henz BM (1998) Microscopic morphology in different types of urticaria. Arch Dermatol 134: 41–46
Haas N, Motel K, Czarnetzki BM (1995) Comparative immunoreactivity of the eosinophil constituents MBP and ECP in different types of urticaria. Arch Dermatol Res 287: 180–185
Czarnetzki BM (1987) Mechanisms and mediators in urticaria. Sem Dermatol 6:272–285
Rosenbach T, Grabbe J, Möller A, Schwanitz HJ, Czarnetzki BM (1985) Generation of leukotrienes from normal epidermis and their demonstration in cutaneous disease. Br J Dermatol (Suppl 28) 113: 157–167
Wassermann SI, Goetzl EJ, Austen KF (1974) Preformed eosinophil chemotactic factor of anaphylaxis (ECF-A). J Immunol 112: 351–358
Czarnetzki BM, König W, Lichtenstein LM (1976) Antigen-induced eosinophil chemotactic factor (ECF) release by human leukocytes. Inflammation 1: 201–215
Wassermann SI, Soter NA, Center DM, Austen KF (1977) Cold urticaria. Recognition and characterisation of a neutrophil chemotactic factor which appears in serum during cold challenge. J Clin Invest 60: 189–196.
Plaut M, Pierce JH, Watson CJ, Hanley-Hyde J, Nordan RP, Paul WE (1989) Mast cell lines produce lymphokines in response to cross-linkage of FcɛRI or to calcium ionophores. Nature 339: 64–67
Möller A, Lippert U, Leßmann D, Kolde G, Hamann K, Welker P, Schadendorf D, Grabbe J, Rosenbach T, Luger T, Czarnetzki BM (1993) Human mast cells produce IL-8. J Immunol 151: 3261–3266
Möller A, Grabbe J, Czarnetzki BM (1991) Mast cells and their mediators in immediate and delayed immune reactions. Skin Pharmacol 4(suppl 1): 56–63
Nilsson G, Blom T, Kusche-Gullberg M, Kjellen L, Butterfield JH, Sundström C, Nils-son K, Hellman L (1994) Phenotypic characterization of the human mast-cell line HMC-1. ScandJ Immunol 39: 489–498
Hamann K, Grabbe J, Welker P, Haas N, Algermissen B, Czarnetzki BM (1994) Phenotypic evaluation of cultured human mast and basophilic cells and of normal human skin mast cells. Arch Dermatol Res 286: 380–385
Möller A, Henz BM, Grützkau A, Lippert U, Schwarz T, Aragane Y, Krüger-Krasagakes S (1998) Comparative cytokine gene expression, regulation and release by human mast cells. Immunology 93: 289–295
Buckley MG, Williams CMM, Thompson J, Pryor P, Ray P, Butterfield JH, Coleman JW (1995) IL-4 enhances IL-3 and IL-8 gene expression in a human leukemic mast cell line. Immunology 84: 410–415
Lippert U, Krüger-Krasagakes S, Möller A, Kiessling U, Czarnetzki BM (1995) Pharmacological modulation of IL-6 and IL-8 secretion by the HI-antagonist descarboethoxy-loratadine and dexamethasone from human mast and basophilic cell lines. Exp Dermatol 4: 272–276
Grützkau A, Krüger-Krasagakes S, Kögel H, Möller A, Lippert U, Henz BM (1997). Detection of intracellular interleukin-8 in the human mast cell line-1: Using flow cytometry as a guide for immunoelectron microscopy. J Histochem Cytochem 45: 935–945
Selvan RS, Butterfield JH, Krangel MS (1994) Expression of multiple chemokine genes by a human mast cell leukemia. J Biol Chem 269: 13893–13898
Safari MN, Garcia-Zepeda EA, MacLean JA, Charo IF, Luster AD (1997) Murine monocyte chemoattractant protein (MCP)-5: A novel CC chemokine that is a structural and functional homologue of human MCP-1. J Exp Med 185: 99–109
Kulmburg PA, Huber NE, Scheer BJ, Wrann M, Baumruker T (1992) Immunoglobulin E plus antigen challenge induces a novel intercrine/chemokine in mouse mast cells. J Exp Med 176: 1773–1778
Jarmin DI, Kulmburg PA, Huber NE, Baumann G, Prieschl-Strassmayr EE, Baumruker T (1994) A transcription factor with AP3-like binding specificity mediates gene regulation after allergic triggering with IgE and Ag in mouse mast cells. J Immunol 153: 5720–5729
Prieschl EE, Pendl GG, Harrer NE, Baumruker T (1995) p21ras links FcRI to NF-AT family member in mast cells. J Immunol 155: 4963–4970
Noso N, Krüger-Krasagakes S, Czarnetzki BM, Schröder JM (1995) Analysis of HMC-1 mast cell-line derived eosinophil attractants. J Invest Dermatol 105: 717
Rumsaeng V, Vliagoftis H, Oh CK, Metcalfe DD (1997) Lymphotactin gene expression in mast cells following Fee receptor I aggregation. J Immunol 158: 1353–1360
Rot A (1992) Binding of neutrophil attractant/activation protein-1 (interleukin 8) to resident dermal cells. Cytokine 4: 347–352
Premack BA, Schall TJ (1996) Chemokine receptors: Gateway to inflammation and infection. Nature Medicine 2: 1174–1178
Lippert U, Artuc M, Grützkau A, Schadendorf D, Möller A, Czarnetzki BM, Krüger-Krasagakes S (1995) Expression and functional activity of the IL-8 receptor in the human mast cell line HMC-1. J Invest Dermatol 105: 717
Lippert U, Artuc M, Grützkau A, Möller A, Kenderessy-Szabo A, Schadendorf D, Norgauer J, Hartmann K, Zuberbier T, Schweizer-Stenner R et al (1998) Expression and functional activity of the IL-8 receptor type CXCR1 and CXCR2 on human mast cells. J Immunol; in press
Nilsson G, Butterfield JH, Nilsson K, Siegbahn A (1994) Stem cell factor is a chemo-tactic factor for human mast cells. J Immunol 153: 3717–3723
Taub D, Dastych J, Inamura N, Upton J, Kelvin D, Metcalfe D, Oppenheim J (1995) Bone marrow-derived murine mast cells migrate, but do not degranulate, in response to chemokines. J Immunol 154: 2393–2402
Hartmann K, Beiglböck F, Czarnetzki BM, Zuberbier T (1995) Effect of CC chemokines on mediator release from human skin mast cells and basophils. Int Arch Allergy Immunol 108: 224–230
Takaishi T, Morita Y, Hirai K, Yamaguchi M, Ohta K, Noda E, Morita T, Ito K, Miyamoto T (1994) Effect of cytokines on mediator release from human dispersed lung mast cells. Allergy 49: 837–842
Petersen LJ, Brasso K, Pryds M, Skov PS (1996) Histamine release in intact human skin by monocyte chemoattractant factor-lα, RANTES, macrophage inflammatory protein-1, stem cell factor, anti-IgE, and codeine as determined by an ex vivo skin microdialysis technique. J Allergy Clin Immunol 98: 790–796
Alam R, Forsythe P, Stafford S, Henrich J, Bravo R, Proost P, van Damme J (1994) Monocyte chemotactic protein-2, monocyte chemotactic protein-3, and fibroblast-induced cytokine. Three new chemokines induce Chemotaxis and activation of basophils. J Immunol 153: 3155–3159
Alam R, Forsythe P, Stafford S, Lett-Brown MA, Grant JA (1992) Macrophage inflammatory protein-1 activates basophils and mast cells. J Exp Med 176: 781–786
Conti P, Boucher W, Letourneau R, Feliciani C, Reale M, Barbacane RC, Vlagopoulos P, Bruneau G, Thibault J, Theoharides TC (1995) Monocyte chemotactic protein-1 provokes mast cell aggregation and 3[H]5HT release. Immunology 86: 434–440
Weber S, Ruh B, Dippel E, Czarnetzki BM (1994) Monoclonal antibodies to leukosialin (CD 43) induce homotypic aggregation of the human mast cell line HMC-1. Characterization of leucosialin on HMC-1 cells. Immunology 82: 638–644
Alam R, Kumar D, Anderson-Walters D, Forsythe P (1994) Macrophage inflammatory protein-la and monocyte chemoattractant peptide-1 elicit immediate and late cutaneous reactions and activate murine mast cells in vivo. J Immunol 152: 1298–1303
Hsieh K-H, Chou CC, Chiang BL (1996) Immunotherapy suppresses the production of monocyte chemotactic and activating factors and augments the production of IL-8 in children with asthma. J Allergy Clin Immunol 98: 580–587
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Basel AG
About this chapter
Cite this chapter
Krüger-Krasagakes, S., Grützkau, A., Lippert, U., Henz, B.M. (1998). Chemokines and mast cells. In: Kownatzki, E., Norgauer, J. (eds) Chemokines and Skin. Progress in Inflammation Research. Birkhäuser, Basel. https://doi.org/10.1007/978-3-0348-8843-1_5
Download citation
DOI: https://doi.org/10.1007/978-3-0348-8843-1_5
Publisher Name: Birkhäuser, Basel
Print ISBN: 978-3-0348-9797-6
Online ISBN: 978-3-0348-8843-1
eBook Packages: Springer Book Archive